Common questions

Selank: questions answered from the research

Direct, cited answers to the questions people most often ask about Selank.

How does Selank work?

Selank works mainly two ways. It acts as a positive allosteric modulator of GABA receptor binding — enhancing the brain's calming GABA system from a secondary site, differently from benzodiazepines [1] — and it inhibits enkephalin-degrading enzymes, stabilizing the body's own anti-stress enkephalins [2]. It also raises hippocampal BDNF and shifts monoamine activity in animals [3].

Does Selank affect GABA receptors?

Yes. Binding data describe Selank as a positive allosteric modulator of [3H]GABA binding, able to block the modulatory activity of diazepam and olanzapine, indicating distinct but overlapping sites [1]. In rat frontal cortex a 300 µg/kg dose changed the expression of GABA-pathway genes, with shifts correlating positively with GABA's own [4].

How does Selank differ from benzodiazepines for anxiety?

Both engage the GABA system, but differently. Selank is a positive allosteric modulator with a subtype-selective, concentration-dependent profile distinct from benzodiazepines [1]. In Russian clinical studies its anxiolytic effect in generalized anxiety disorder was comparable to a benzodiazepine comparator but without the sedation, cognitive impairment, or withdrawal signal [5]. This describes study findings, not a treatment claim.

Is Selank addictive or does it cause withdrawal?

In the available clinical studies, intranasal Selank produced its anxiolytic effect without the dependence or withdrawal seen with benzodiazepines [5]. Community reports echo no tolerance escalation or rebound. However, this rests on short-term, limited data, not long human safety trials, so the long-term picture is not established and psychological reliance remains possible.

Does Selank affect gene expression?

Yes. A single 300 µg/kg dose in rat frontal cortex significantly changed the expression of 45 genes at one hour and 22 at three hours, with shifts correlating positively with GABA's effects [4]. In human IMR-32 neuroblastoma cells, Selank likewise altered the expression of GABAergic-neurotransmission genes [11].

What is Selank?

Selank is a synthetic heptapeptide (sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, also called TP-7) developed in Russia as a stabilized analogue of the natural immune peptide tuftsin [13]. It is studied as a non-sedating anxiolytic and nootropic, acting mainly through the GABA and enkephalin systems [1][2]. It is not FDA-approved.

What does Selank do?

In research, Selank reduces anxiety-related behavior without sedation, enhances GABA-receptor responses [1], inhibits enkephalin-degrading enzymes [2], raises hippocampal BDNF [3], and modulates immune cytokines [6]. These are study-attributed effects in animals and small clinical trials, not proof it treats any disorder.

What is Selank peptide used for?

In the research literature, the Selank peptide is studied primarily for anxiety, where Russian clinical work reported anxiolytic benefit without benzodiazepine-style side effects [5], and for nootropic and neuroprotective effects linked to its BDNF and monoamine activity [3]. It is also studied as a tuftsin-derived immunomodulator [6]. These are research uses, not approved indications.

Is Selank a nootropic?

It is studied as one. In rats, Selank was used to correct measures of integrative brain activity and biogenic amine levels [12], and its modulation of hippocampal BDNF provides a neuroplasticity-linked basis for cognitive effects [3]. Reported clarity and focus in humans are anecdotal, not from controlled cognitive testing.

What is Selank used for in research?

Research uses span anxiety (GABAergic and enkephalinase mechanisms) [1][2], neurotrophic signaling (hippocampal BDNF) [3], and immune modulation — in patients with anxiety-asthenic disorders Selank altered the Th1/Th2 cytokine balance and modulated IL-6, characterizing it as an immunomodulator alongside its anxiolytic action [6].

What is the difference between Selank and Semax?

They are distinct peptides. Selank derives from tuftsin (an immune peptide) and is studied mainly as an anxiolytic [13]; Semax derives from an ACTH fragment and is studied mainly as a neuroprotective nootropic. They share one mechanism — both inhibit enkephalin-degrading enzymes in human serum [8] — but should never be conflated.

Does Selank increase BDNF in the hippocampus?

Yes, in rats. Intranasal administration of Selank regulated (increased) BDNF expression in the rat hippocampus in vivo, linking the peptide to neurotrophic signaling [3]. This is an animal finding; it has not been demonstrated in humans, and it supports rather than proves a cognitive mechanism.

Does Selank help with memory and focus?

Animal data are suggestive: intranasal Selank increased hippocampal BDNF, a protein central to learning and memory [3], and it corrected indices of integrative brain activity in rats [12]. Human reports of sharper focus are anecdotal and tied to anxiety relief rather than measured cognitive gains, so this is not established in people.

Does Selank affect serotonin and dopamine?

Yes, in animals. In BALB/c and C57Bl/6 mice, the heptapeptide altered the content of serotonin and dopamine and their metabolites in a strain-dependent manner [17], and in rats Selank was used to correct biogenic amine levels alongside integrative brain activity [12]. These monoaminergic effects accompany its GABA and opioid mechanisms.

How does Selank modulate the immune system?

As a tuftsin analogue, Selank acts as an immunomodulator. In patients with anxiety-asthenic disorders it altered the Th1/Th2 cytokine balance and modulated IL-6 [6], in stressed rats it influenced cytokine levels [18], and in mice it showed antiviral activity against experimental influenza [19].

How does Selank affect cytokine levels under stress?

In rats under stress conditions, Selank modulated cytokine levels, supporting an immunomodulatory role under stress load [18]. In patients with anxiety-asthenic disorders it shifted the Th1/Th2 cytokine balance and modulated peripheral-blood IL-6 [6]. These results frame Selank as acting on immune signaling, not only on anxiety.

Has Selank been studied for alcohol or opioid withdrawal?

Its opioid-system activity is documented — naloxone abolished Selank's behavioral effect in rats, implicating endogenous opioids [9] — and in unpredictable chronic mild stress, diazepam combined with Selank was the most effective at reducing anxiety, restoring behavior toward pre-stress levels [7]. Dedicated, well-replicated withdrawal-syndrome studies are not part of the citable record here.

Is Selank FDA approved?

No. Selank is not approved by the FDA or EMA for any indication. Its regulatory registration as an anxiolytic exists essentially only in Russia, where intranasal Selank was studied in generalized anxiety disorder [5]. In the United States it is sold strictly as a research chemical and is not intended for human consumption.

Is Selank legal in the United States?

Selank is not a controlled substance in the United States, but it is also not FDA-approved for any use; it is sold only as a research chemical, not as a medicine or supplement, and is not intended for human consumption. Its anxiolytic registration exists essentially only in Russia [6]. Regulatory status can change, so this is general information, not legal advice.

How long does Selank take to work?

There is no validated human onset figure in mainstream literature. Russian clinical studies used multi-week intranasal courses for anxiety outcomes [5], while community reports of the intranasal route describe a noticeable shift within roughly 20 to 40 minutes — anecdotal timing, not a measured pharmacokinetic result. Rodent gene-expression effects appeared within one hour [4].

Does Selank have effects on the gut or stomach?

Yes, in rats. The synthetic anxiolytic Selank increased gastric wall blood flow and supported mucosal protection [14], and Selank with its metabolites preserved gastric mucosal homeostasis under challenge [15]. These gastrointestinal effects are part of its broader physiological profile observed in animal studies.

Should Semax and Selank be taken together in research?

The two have been examined side by side in research — both inhibit enkephalin-degrading enzymes in human serum [8] — but they are distinct molecules with different primary effects, and no study establishes that combining them is interchangeable or additive in a defined way. Any combined research use is extrapolation. This is not a usage recommendation.